Comparative Study
doi: 10.1111/j.1572-0241.2003.07205.x.
Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis
- PMID: 12526968
- DOI: 10.1111/j.1572-0241.2003.07205.x
Item in Clipboard
Comparative Study
Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis
Am J Gastroenterol.
2003 Jan.
No abstract available
Comment in
-
Treatment of ulcerative colitis with balsalazide: response to editorial by Drs. Farrell and Peppercorn and letter to the editor by Dr. Hanauer.Am J Gastroenterol. 2003 Jan;98(1):216-9. doi: 10.1111/j.1572-0241.2003.07204.x. Am J Gastroenterol. 2003. PMID: 12526969 No abstract available.
Comment on
-
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.Am J Gastroenterol. 2002 Jun;97(6):1398-407. doi: 10.1111/j.1572-0241.2002.05781.x. Am J Gastroenterol. 2002. PMID: 12094857 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
